-
Cboe Completes Sale of Cboe Australia to TMX Group
- August 2, 2026
- Posted by: Jessica Turner
- Category: Finance & accounting
No Comments
CHICAGO, Aug. 2, 2026 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity and index derivatives, today announced it has completed the sale of Cboe Australia (now TMX Australia Exchange)…
-
Mezzion Reports Positive In Vivo Results for Udenafil in ADPKD
- August 2, 2026
- Posted by: Megan Foster
- Category: Business plans
Seoul, Korea, Aug. 2, 2026 /PRNewswire/ — Mezzion Pharma Co., Ltd. today announced positive results from a new in vivo study of udenafil, a novel phosphodiesterase type 5 (PDE5) inhibitor, in autosomal dominant polycystic kidney disease (ADPKD). In…
-
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
- August 2, 2026
- Posted by: Victoria Reynolds
- Category: Economics
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical Benefits Scheme (PBS) for adults with relapsed or refractory follicular lymphoma (R/R FL)…